|
Volumn 288, Issue 4, 2001, Pages 868-874
|
Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB4 dehydrogenase
a a a |
Author keywords
Dehydrogenase reductase; Inflammation; Leukocytes; Leukotrienes; Lipoxins; Nons teroidal anti inflammatory drugs; Prostaglandins
|
Indexed keywords
13,14 DIHYDRO 15 OXOPROSTAGLANDIN E2;
15 HYDROXYPROSTAGLANDIN DEHYDROGENASE;
15 OXOPROSTAGLANDIN 13 REDUCTASE;
15 OXOPROSTAGLANDIN E2;
CYCLOOXYGENASE EICOSANOID OXIDOREDUCTASE INHIBITOR;
DICLOFENAC;
INDOMETACIN;
LEUKOTRIENE;
LEUKOTRIENE B4 12 HYDROXYDEHYDROGENASE;
LIPOXIN A;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OXIDOREDUCTASE;
OXIDOREDUCTASE INHIBITOR;
PROSTAGLANDIN DERIVATIVE;
PROSTAGLANDIN E2;
UNCLASSIFIED DRUG;
ARTICLE;
CATALYSIS;
ENZYME ACTIVITY;
ENZYME DEGRADATION;
ENZYME INACTIVATION;
ENZYME INHIBITION;
ENZYME METABOLISM;
INFLAMMATION;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
|
EID: 0035834581
PISSN: 0006291X
EISSN: None
Source Type: Journal
DOI: 10.1006/bbrc.2001.5841 Document Type: Article |
Times cited : (38)
|
References (25)
|